Bank of New York Mellon Corp - ATOSSA THERAPEUTICS INC ownership

ATOSSA THERAPEUTICS INC's ticker is ATOS and the CUSIP is 04962H506. A total of 52 filers reported holding ATOSSA THERAPEUTICS INC in Q4 2022. The put-call ratio across all filers is 0.26 and the average weighting 0.0%.

Quarter-by-quarter ownership
Bank of New York Mellon Corp ownership history of ATOSSA THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$81,640
-42.5%
110,848
-1.6%
0.00%
Q2 2023$141,947
+29.4%
112,656
-25.5%
0.00%
Q1 2023$109,663
+37.2%
151,2800.0%0.00%
Q4 2022$79,951
-37.0%
151,280
-0.5%
0.00%
Q3 2022$127,000
-23.5%
152,0520.0%0.00%
Q2 2022$166,000
-74.0%
152,052
-70.2%
0.00%
Q1 2022$639,000
-23.2%
510,540
-1.8%
0.00%
Q4 2021$832,000
-46.5%
519,658
+8.9%
0.00%
Q3 2021$1,556,000
-47.1%
477,291
+2.5%
0.00%
-100.0%
Q2 2021$2,943,000
+3772.4%
465,572
+1195.9%
0.00%
Q1 2021$76,00035,9270.00%
Other shareholders
ATOSSA THERAPEUTICS INC shareholders Q4 2022
NameSharesValueWeighting ↓
QCM Cayman, Ltd. 22,301$36,0000.22%
XTX Topco Ltd 17,275$28,0000.02%
TWO SIGMA INVESTMENTS, LP 2,371,193$3,794,0000.01%
TWO SIGMA ADVISERS, LP 1,597,930$2,557,0000.01%
D. E. Shaw & Co., Inc. 4,147,809$6,637,0000.01%
SUSQUEHANNA FUNDAMENTAL INVESTMENTS, LLC 129,916$208,0000.01%
Graham Capital Management, L.P. 73,105$116,0000.01%
Caption Management, LLC 300,000$480,0000.01%
Engineers Gate Manager LP 60,809$97,0000.00%
Castleview Partners, LLC 800$500,0000.00%
View complete list of ATOSSA THERAPEUTICS INC shareholders